A multicenter, dose-finding, phase 1b study of imatinib in combination with alpelisib as third-line treatment in patients with advanced gastrointestinal stromal tumor
暂无分享,去创建一个
A. Italiano | M. Heinrich | H. Gelderblom | P. Reichardt | C. Valverde | A. Reyners | P. Schöffski | M. Pantaleo | U. Brandt | S. Bauer | G. Grignani | T. Stefanelli | Daniel Stark | Ghimja Berhanu